Vestcor Inc Vertex Pharmaceuticals Inc Transaction History

Vestcor Inc

$3.02 Billion
Q4 2024

A detailed history of Vestcor Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Vestcor Inc holds 52,631 shares of VRTX stock, worth $25.2 Million. This represents 0.7% of its overall portfolio holdings.

Number of Shares

52,631

Previous 65,255 19.35%

Holding current value

$25.2 Million

Previous $30.3 Million 30.16%

% of portfolio

0.7%

Previous 0.96%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	SELL	$396.64 - $516.74 $5.01 Million - $6.52 Million	-12,624 Reduced 19.35%	52,631 $21.2 Million
Q3 2024 Nov 15, 2024	BUY	$460.0 - $505.78 $563,040 - $619,074	1,224 Added 1.91%	65,255 $30.3 Million
Q2 2024 Aug 13, 2024	SELL	$392.81 - $485.53 $283,216 - $350,067	-721 Reduced 1.11%	64,031 $30 Million
Q1 2024 May 14, 2024	SELL	$407.69 - $446.08 $2.53 Million - $2.76 Million	-6,196 Reduced 8.73%	64,752 $27.1 Million
Q4 2023 Feb 14, 2024	SELL	$343.0 - $410.68 $701,092 - $839,429	-2,044 Reduced 2.8%	70,948 $28.9 Million
Q3 2023 Nov 14, 2023	SELL	$338.18 - $362.46 $1.09 Million - $1.16 Million	-3,213 Reduced 4.22%	72,992 $25.4 Million
Q2 2023 Aug 15, 2023	SELL	$314.42 - $351.91 $462,197 - $517,307	-1,470 Reduced 1.89%	76,205 $26.8 Million
Q1 2023 May 15, 2023	SELL	$283.23 - $323.1 $1.86 Million - $2.12 Million	-6,571 Reduced 7.8%	77,675 $24.5 Million
Q4 2022 Feb 15, 2023	BUY	$285.76 - $321.48 $1.29 Million - $1.45 Million	4,524 Added 5.67%	84,246 $24.3 Million
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $1.37 Million - $1.53 Million	5,020 Added 6.72%	79,722 $23.1 Million
Q2 2022 Aug 15, 2022	BUY	$234.96 - $292.55 $703,470 - $875,894	2,994 Added 4.18%	74,702 $21.1 Million
Q1 2022 May 16, 2022	BUY	$221.42 - $260.97 $14.5 Million - $17.1 Million	65,551 Added 1064.66%	71,708 $18.7 Million
Q4 2021 Feb 15, 2022	SELL	$177.01 - $223.45 $167,628 - $211,607	-947 Reduced 13.33%	6,157 $1.35 Million
Q3 2021 Nov 15, 2021	SELL	$181.39 - $202.99 $7.05 Million - $7.89 Million	-38,882 Reduced 84.55%	7,104 $1.29 Million
Q2 2021 Aug 16, 2021	SELL	$187.49 - $221.1 $113,431 - $133,765	-605 Reduced 1.3%	45,986 $9.27 Million
Q1 2021 May 17, 2021	BUY	$207.02 - $241.31 $1.61 Million - $1.88 Million	7,785 Added 20.06%	46,591 $10 Million
Q4 2020 Feb 16, 2021	BUY	$207.01 - $276.09 $2.44 Million - $3.26 Million	11,804 Added 43.72%	38,806 $9.17 Million
Q3 2020 Nov 16, 2020	BUY	$255.65 - $303.1 $1.14 Million - $1.35 Million	4,464 Added 19.81%	27,002 $7.35 Million
Q2 2020 Aug 14, 2020	BUY	$225.48 - $295.8 $3.84 Million - $5.04 Million	17,032 Added 309.34%	22,538 $6.54 Million
Q1 2020 May 13, 2020	BUY	$199.77 - $247.81 $209,159 - $259,457	1,047 Added 23.48%	5,506 $1.31 Million
Q4 2019 Feb 12, 2020	BUY	$166.71 - $223.91 $743,359 - $998,414	4,459 New	4,459 $976,000

Others Institutions Holding VRTX

# of Institutions

1,753

Shares Held

227M

Call Options Held

1.63M

Put Options Held

1.47M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $123B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vestcor Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vestcor Inc with notifications on news.

Account